Journals / Journal of the Turkish-German Gynecological Association / 2007 / Cilt: 8 - Sayı: 1

Gestasyonel diabet taramasında normal test değeri ve tek değer yüksekliği saptanan gebelerde perinatal sonuçlar

Perinatal outcome in women screened for gestational diabetes mellitus with normal or with one elevated glucose tolerance test value

Pages
38–43
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to the results 360 women were with a normal screening test (Group 1), 87 with a positive screening and all normal test values on OGTT (Group 2), 50 with a positive screening but a single abnormal test value on OGTT (gestational impaired glucose tolerance, Group 3) and 79 were diagnosed as with GDM (Group 4).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To investigate the perinatal outcome of women screened for gestational diabetes mellitus (GDM) who had abnormal screening and normal oral glucose tolerance test (OGTT) results or women with a single abnormal test value on OGTT.
📊
Key Findings & Data:MATERIALS-METHODS: We screened 576 pregnant women with a 50-gr oral glucose challenge test between the 24th and 26th weeks’ of gestation.
💡
Conclusion & Impact:According to the results 360 women were with a normal screening test (Group 1), 87 with a positive screening and all normal test values on OGTT (Group 2), 50 with a positive screening but a single abnormal test value on OGTT (gestational impaired glucose tolerance, Group 3) and 79 were diagnosed as with GDM (Group 4).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: To investigate the perinatal outcome of women screened for gestational diabetes mellitus (GDM) who had abnormal screening and normal oral glucose tolerance test (OGTT) results or women with a single abnormal test value on OGTT. MATERIALS-METHODS: We screened 576 pregnant women with a 50-gr oral glucose challenge test between the 24th and 26th weeks’ of gestation. Women with abnormal diabetes screening test results were followed up with standard OGTT with a 100-gr oral glucose load. According to the results 360 women were with a normal screening test (Group 1), 87 with a positive screening and all normal test values on OGTT (Group 2), 50 with a positive screening but a single abnormal test value on OGTT (gestational impaired glucose tolerance, Group 3) and 79 were diagnosed as with GDM (Group 4). Diet or diet plus insulin therapy was initiated to patients in Groups 3 and 4 as indicated. We compared perinatal outcome between these four groups. Statistical data were calculated with Post-hoc multiple comparison, Kruskal-Wallis and Chi-square tests for comparison of means, medians or for nominal variables. RESULTS: Women with GDM had significantly higher glycosylated hemoglobin levels, large for gestational age infants, macrosomia, neonatal jaundice, neonatal intensive care unit (NICU) admission and neonatal mortality rates but lower gestational age at delivery and 1-minute Apgar scores compared to controls. Also, there were significant differences in neonatal jaundice and NICU admission rates between Groups 1 and 3, or between 2 and 3. There were significantly more macrosomic babies in Groups 3 and 4, compared to Group 2. CONCLUSION: Women with abnormal diabetes screening tests and negative OGTT or with gestational impaired glucose tolerance seem not to be prone to develop severe adverse perinatal outcome.

Özet

AMAÇ: Gestasyonel diabet (GDM) taraması yapılan ve oral glikoz tolerans testinde (OGTT) tüm değerleri normal ve tek değeri yüksek çıkan hastalardaki perinatal sonuçları incelemek. Materyal ve Metot: Gebeliğin 24-26. haftaları arasında 576 hastaya 50-gr “glikoz tarama testi” uygulandı. Test sonucu yüksek bulunanlara 100-gr glikoz ile standart OGTT yapıldı. Sonuçta 360 hastada glikoz tarama testi normal (Grup 1), 87 hastada glikoz tarama testi yüksek-OGTT normal (Grup 2) bulunurken, 50 hastada glikoz tarama testi yüksek-OGTT’de tek değer yüksekliği (gebelik glukoz intoleransı, Grup 3) ve 79 hastada GDM (Grup 4) saptandı. Grup 3 ve 4’deki hastalara diyet ve gerektiğinde diyetle birlikte insulin tedavisi başlandı. Bu dört gruptaki perinatal sonuçlar karşılaştırıldı. İstatistiksel analizde Post-hoc çoklu karşılaştırma, Kruskal-Wallis ve ki-kare testleri kullanıldı. SONUÇLAR: GDM tanısı alanlarda kontrol grubuna kıyasla glikozile hemoglobin (HbA1c), fazla doğum ağırlıklı bebek, makrozomi, neonatal sarılık, neonatal yoğun bakım ünitesi (NICU) alınma ve neonatal mortalite oranları anlamlı olarak fazla, doğum haftaları ve 1. dakika Apgar skorları düşük saptandı. Ayrıca, neonatal sarılık ve NICU alınma oranları Grup 1 ve 3, Grup 2 ve 3 arasında da anlamlı olarak farklı izlendi. Grup 3 ve 4’de ise Grup 2’ye kıyasla daha fazla makrozomik bebek dünyaya geldi. TARTIŞMA: Diabet tarama testi yüksek çıkıp OGTT negatif bulunan veya gebelik glukoz intoleransı saptanan gebeler ciddi olumsuz perinatal sonuçlara aday görünmemektedirler.

🔖

Cite This Article

SAYIN, N. C., VAROL, F. G., KURY, İ., ACUNAŞ, B., DURAN, R. (2022). Gestasyonel diabet taramasında normal test değeri ve tek değer yüksekliği saptanan gebelerde perinatal sonuçlar. Journal of the Turkish-German Gynecological Association, Cilt: 8 - Sayı: 1, 38–43. https://ajindex.com/articles/567931

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. American Diabetes Association position statement: gestational diabetes mellitus. Diabetes Care 2003;26 (Suppl. 1):S103-5
  2. Beischer NA, Wein P, Sheedy MT, Steffen B. Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust NZ J Obstet Gynaecol 1996;36:239-47
  3. Langer O. Is normoglycemia the correct threshold to prevent complications in the pregnant diabetic patient? Diabetes Rev 1996;4:2-10
  4. Langer O, Levy S, Brustman L et al. Glycemic control in GDM: how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol 1989;161:646-53
  5. Khan KS, Syed AH, Hashmi FA, Rizvi JH. Relationship of fetal macrosomia to a 75-g glucose challenge test in nondiabetic pregnant women. Aust NZ J Obstet Gynecol 1994;34:24-7
  6. Hod M, Rabinerson D, Kaplan B et al. Perinatal complications following gestational diabetes mellitus: How sweet is ill? Acta Obstet Gynecol Scand 1996;75:809-15
  7. Jacobson JD, Cousins L. A population-based study of maternal and perinatal outcome in patients with gestational diabetes. Am J Obstet Gynecol 1989;161:981-6
  8. Langer O, Brustman L, Anyaegbunam A, Mazze R. The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy. Am J Obstet Gynecol 1987;157:758-63
  9. Lindsay MK, Graves W, Klein L. The relationship of one abnormal glucose tolerance test value and pregnancy complications. Obstet Gynecol 1989;73:103-6
  10. Vambergue A, Nuttens MC, Verier-Mine O et al. Is mild gestational hyperglycaemia associated with maternal and neonatal complications? The Diagest Study. Diabet Med 2000;17:203-8
  11. Sendag F, Terek MC, Itil IM et al. Maternal and perinatal outcomes in women with gestational diabetes mellitus as compared to nondiabetic controls. J Reprod Med 2001;46:1057-62
  12. Berkus MD, Langer O. Glucose tolerance test: degree of glucose abnormality correlates with neonatal outcome. Obstet Gynecol 1993;81:344-8
  13. Bofill JA, Andrew ME, Kincaid TA et al. Lowering the threshold for the diagnosis of gestational diabetes. Am J Obstet Gynecol 1996;175(4 Pt 1):961-5
  14. Lucas MJ, Lowe TW, Bowe L, McIntire DD. Class A1 gestational diabetes: A meaningful diagnosis? Obstet Gynecol 1993;82:260-5
  15. Ergin T, Lembet A, Duran H et al. Does insulin secretion in patients with one abnormal glucose tolerance test value mimic gestational diabetes mellitus? Am J Obstet Gynecol 2002;186:204-9. 1